We are live on ! Find out more
ADEF

Adams Diversified Equity Fund Portfolio holdings

AUM $3.27B
1-Year Est. Return 45.57%
This Fund
S&P 500
This Quarter Est. Return
+4.22%
1 Year Est. Return
+45.57%
3 Year Est. Return
+150.13%
5 Year Est. Return
+214.77%
10 Year Est. Return
+830.6%
AUM
$1.49B
AUM Growth
$0
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
27.06%
Holding
197
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 18.6%
2 Healthcare 15.21%
3 Technology 11.65%
4 Communication Services 10.84%
5 Consumer Staples 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSE
176
DELISTED
Trinseo
TSE
$313K 0.02%
7,300
– –
NXGN
177
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$311K 0.02%
26,100
– –
LGND icon
178
Ligand Pharmaceuticals
LGND
$5.76B
$310K 0.02%
4,168
– –
PENN icon
179
PENN Entertainment
PENN
$2.75B
$300K 0.02%
21,500
– –
THRM icon
180
Gentherm
THRM
$1.25B
$291K 0.02%
8,500
– –
CALM icon
181
Cal-Maine
CALM
$4.12B
$288K 0.02%
6,500
– –
GSBC icon
182
Great Southern Bancorp
GSBC
$874M
$285K 0.02%
7,700
– –
AEIS icon
183
Advanced Energy
AEIS
$11.6B
$281K 0.02%
7,400
– –
HSKA
184
DELISTED
Heska Corp
HSKA
$279K 0.02%
7,500
– –
BSTC
185
DELISTED
BioSpecifics Technologies Corp.
BSTC
$272K 0.02%
6,800
– –
LAD icon
186
Lithia Motors
LAD
$8.47B
$270K 0.02%
3,800
– –
TBHC
187
DELISTED
The Brand House Collective
TBHC
$267K 0.02%
18,200
– –
PBH icon
188
Prestige Consumer Healthcare
PBH
$2.38B
$266K 0.02%
4,800
– –
SIGM
189
DELISTED
Sigma Designs Inc
SIGM
$241K 0.02%
37,500
– –
AGTC
190
DELISTED
Applied Genetic Technologies Corporation
AGTC
$239K 0.02%
16,900
– –
NBIX icon
191
Neurocrine Biosciences
NBIX
$16.8B
$223K 0.02%
4,900
– –
PDLI
192
DELISTED
PDL BioPharma, Inc.
PDLI
$217K 0.01%
69,200
– –
WNR
193
DELISTED
Western Refining Inc
WNR
$204K 0.01%
9,900
– –
EBS icon
194
Emergent Biosolutions
EBS
$373M
$202K 0.01%
7,200
– –
LCI
195
DELISTED
Lannett Company, Inc.
LCI
$197K 0.01%
2,075
– –
ENTA icon
196
Enanta Pharmaceuticals
ENTA
$366M
$194K 0.01%
8,800
– –
MYGN icon
197
Myriad Genetics
MYGN
$270M
$187K 0.01%
6,100
– –
4 5 6 7
8

Similar funds

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
MWM
Moran Wealth Management Naples, Florida $3.27B AUM 25.8% 1-Year Est. Return
AFG
Atomi Financial Group New York $3.26B AUM 32.85% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.29B AUM 2.24% 1-Year Est. Return
FEG
Fund Evaluation Group Cincinnati, Ohio $3.25B AUM 14.16% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
HIMC
Heritage Investors Management Corp Bethesda, Maryland $3.29B AUM 26.44% 1-Year Est. Return
SM
SCGE Management Menlo Park, California $3.3B AUM 18.27% 1-Year Est. Return

Adams Diversified Equity Fund's Q3 2016 Portfolio in Review

As of Q3 2016, Adams Diversified Equity Fund held 197 positions worth $1.49B, unchanged from the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Trading was light in Q3 2016: portfolio turnover was 0%. Adams Diversified Equity Fund opened no new positions and made no exits, leaving the 197-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 19% of assets, unchanged from a quarter earlier, followed by Healthcare and Technology.

  • Adams Diversified Equity Fund's ten largest holdings make up 27% of its $1.49B portfolio in Q3 2016.
  • Adams Diversified Equity Fund opened 0 new positions and closed 0 in Q3 2016.
  • Adams Diversified Equity Fund's portfolio value was unchanged quarter-over-quarter at $1.49B.

Based on Adams Diversified Equity Fund's 13F filing for Q3 2016, filed 24 Oct 2016.